AstraZeneca · 19 hours ago
HPP-Patient Marketing Intern (Undergraduate)
AstraZeneca is a global biopharmaceutical company, and they are seeking an undergraduate intern for their Patient Marketing team. The intern will provide operational support for patient marketing projects, assist in creating educational materials, and develop social media content.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Provide operational support for patient marketing projects, coordinating deliverables, timelines, and the promotional review process
Supporting the creation of patient education materials and their rollout to the internal and external HPP community in July
Assisting with development of slide decks, agendas, and follow-up communications for internal stakeholders
Supporting the development of social media content for the HPP Patient Marketing Team’s five social media channels (posted quarterly) from content development and PRC review to metrics evaluation
Qualification
Required
Sophomore and Junior students majoring in Communications, Biology, Chemistry, Biochemistry, Business, or a related field
Candidates must have an expected graduation date after August 2026
Expressed interest in pharmaceutical industry
US Work Authorization is required at time of application
Ability to report onsite to the Seaport neighborhood in Boston, MA site 3 days per week
Preferred
Basic project management skills such as managing multiple timelines and coordinating deliverables are a plus
Social media skills are a plus
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design
Benefits
Short-term incentive bonus opportunity
Equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Leadership Team
Recent News
2026-01-09
2026-01-09
News Powered by Cision
2026-01-08
Company data provided by crunchbase